Profile data is unavailable for this security.
About the company
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.
- Revenue in USD (TTM)441.25k
- Net income in USD-2.03m
- Incorporated2022
- Employees3.00
- Location60 Degrees Pharmaceuticals Inc1025 Connecticut Avenue Nw, Suite 1000WASHINGTON 20036United StatesUSA
- Phone+1 (202) 327-5422
- Fax+1 (302) 636-5454
- Websitehttps://60degreespharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pure Harvest Corporate Group Inc | 2.48m | -6.67m | 223.19k | 25.00 | -- | 0.1115 | -- | 0.0901 | -0.0901 | -0.0901 | 0.0383 | 0.0201 | 0.2644 | 1.46 | 40.64 | 99,070.40 | -70.96 | -- | -136.76 | -- | 33.83 | -- | -268.37 | -- | 0.5886 | -0.866 | 0.7639 | -- | 1,808.41 | -- | -459.26 | -- | -- | -- |
TRACON Pharmaceuticals Inc | 3.20m | 5.20m | 340.76k | 17.00 | 0.0264 | -- | 0.0654 | 0.1065 | 3.79 | 3.79 | 1.39 | -0.9065 | 0.3267 | -- | -- | 188,235.30 | 53.04 | -79.42 | -- | -177.85 | -- | -- | 162.34 | -813.81 | -- | -19.35 | -- | -- | -- | 32.05 | 87.68 | -- | -- | -- |
Life Stem Genetics Inc | 0.00 | -568.02k | 393.34k | 1.00 | -- | 0.21 | -- | -- | -0.013 | -0.013 | 0.00 | 0.0076 | 0.00 | -- | -- | 0.00 | -198.83 | -- | -330.32 | -- | -- | -- | -- | -- | -- | -- | 0.0241 | -- | -- | -- | -- | -- | -- | -- |
ITonis Inc | 0.00 | -1.17m | 609.36k | -- | -- | -- | -- | -- | -0.0012 | -0.0012 | 0.00 | -0.0004 | 0.00 | -- | -- | -- | -187.63 | -- | -1,169.36 | -- | -- | -- | -- | -- | -- | -0.8999 | -- | -- | -- | -- | -506.86 | -- | -- | -- |
Resonate Blends Inc | 751.28k | -1.88m | 688.81k | 6.00 | -- | -- | -- | 0.9169 | -0.0205 | -0.0205 | 0.0083 | -0.0244 | 0.632 | -- | 11.93 | -- | -158.40 | -680.29 | -- | -- | 46.92 | -78.88 | -250.64 | -12,895.26 | -- | -2.30 | 4.00 | -- | -66.73 | -56.57 | -316.63 | -- | -- | -- |
CanaQuest Medical Corp | 0.00 | -806.83k | 782.59k | -- | -- | -- | -- | -- | -0.0513 | -0.0513 | 0.00 | -0.037 | 0.00 | -- | -- | -- | -1,084.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 57.42 | -- | -- | -- |
PainReform Ltd | 0.00 | -17.67m | 784.60k | 6.00 | -- | -- | -- | -- | -41.92 | -41.92 | 0.00 | -3.53 | 0.00 | -- | -- | 0.00 | -309.43 | -55.47 | -650.22 | -68.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -6.28 | -- | -- | -- |
Bespoke Extracts Inc | 956.86k | -1.36m | 824.67k | 10.00 | -- | -- | -- | 0.8619 | -0.1331 | -0.1331 | 0.0941 | -0.194 | 2.29 | 20.10 | 21.36 | 95,686.00 | -325.13 | -- | -- | -- | 45.50 | -- | -141.75 | -- | 0.0482 | -53.38 | -- | -- | 22,933.72 | -- | 63.98 | -- | -- | -- |
60 Degrees Pharmaceuticals Inc | 441.25k | -2.03m | 1.05m | 3.00 | 1.10 | -- | -- | 2.39 | 0.9455 | 0.9455 | 0.6336 | 2.98 | 0.0755 | 0.8355 | 2.09 | 147,083.30 | -27.71 | -- | -- | -- | 15.59 | -- | -366.89 | -- | 2.74 | -- | 0.0505 | -- | -50.40 | -- | 35.51 | -- | -- | -- |
Evofem Biosciences Inc | 17.71m | 57.36m | 1.10m | 37.00 | 0.0007 | -- | 0.0192 | 0.0623 | -0.4918 | -0.4918 | 0.0297 | -0.7803 | 1.57 | 1.81 | 3.61 | 478,756.80 | 534.21 | -211.64 | -- | -- | 75.75 | -- | 341.16 | -1,031.55 | 0.0841 | -4.50 | -- | -- | 8.20 | -- | 164.08 | -- | -10.59 | -- |
Gold River Productions Inc. | -100.00bn | -100.00bn | 1.24m | 1.00k | -- | 1.91 | -- | -- | -- | -- | -- | 0.0005 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -100.11 | -- | -- | -- |
Procyon Corp | 4.77m | -387.79k | 1.50m | 17.00 | -- | 0.7086 | -- | 0.3151 | -0.0478 | -0.0478 | 0.5891 | 0.2774 | 1.39 | 1.94 | 9.60 | 280,817.70 | -10.81 | 3.52 | -13.69 | 4.23 | 78.01 | 73.30 | -7.78 | 2.52 | 2.22 | -- | 0.00 | -- | -3.22 | 3.11 | 70.44 | -- | 30.98 | -- |